Clinical course and outcomes of pemphigus vulgaris and foliaceus: A retrospective study using a nationwide database in Japan

• 資料種別: 記事
• タイトル: Clinical course and outcomes of pemphigus vulgaris and foliaceus: A retrospective study using a nationwide database in Japan
• 著者標目: Hideaki Miyachi; https://orcid.org/0000-0003-2549-6690; Takaaki Konishi; https://orcid.org/0000-0002-9538-4419; Yohei Hashimoto; https://orcid.org/0000-0002-7944-6923; Hiroki Matsui; https://orcid.org/0000-0003-0004-4743; Kiyohide Fushimi; https://orcid.org/0000-0002-1894-0290; Takashi Inozume; Hideo Yasunaga; https://orcid.org/0000-0002-6017-469X
• 出版年月日等: 2022-11-24
• 出版年（W3CDTF）: 2022-11-24
• タイトル（掲載誌）: The Journal of Dermatology
• 巻号年月日等（掲載誌）: 50 2
• 掲載巻: 50
• 掲載号: 2
• 掲載ページ: 212-221
• 掲載年月日（W3CDTF）: 2022-11-24
• ISSN（掲載誌）: 03852407
• 出版事項（掲載誌）: Wiley
• 件名標目: Japan; Disease Progression; Humans; Pemphigus; Immunosuppressive Agents; Aged; Retrospective Studies
• 対象利用者: 一般
• 標準番号（その他）: PMID : 36424909
• DOI: 10.1111/1346-8138.16641
• 作成日（W3CDTF）: 2022-11-25
• オンライン閲覧公開範囲: インターネット公開
• 著作権情報: http://creativecommons.org/licenses/by-nc/4.0/
• 関連情報（URI）: https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.16641; https://onlinelibrary.wiley.com/doi/full-xml/10.1111/1346-8138.16641
• 参照: Trends in mortality and morbidity in patients with bullous pemphigoid before and after approval of intravenous immunoglobulin in Japan: an interrupted time-series analysis; https://cir.nii.ac.jp/crid/1360580232415040256
• 参照: Diagnosis and Treatment of Pemphigus; https://cir.nii.ac.jp/crid/1360004238625702784; Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open‐label, single‐arm, phase 1/2 study on 10 Japanese patients; https://cir.nii.ac.jp/crid/1360011146139986816; Analysis of clinical characteristics, prognosis and antibody pathogenicity of pemphigus patients positive for anti‐desmoglein IgG autoantibodies in remission: a retrospective cohort study; https://cir.nii.ac.jp/crid/1360013168777740800; Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan; https://cir.nii.ac.jp/crid/1360013168880297472; Association of Early Systemic Corticosteroid Therapy with Mortality in Patients with Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis: A Retrospective Cohort Study Using a Nationwide Claims Database; https://cir.nii.ac.jp/crid/1360013172129431040; Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies; https://cir.nii.ac.jp/crid/1360017287052173440; The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies*; https://cir.nii.ac.jp/crid/1360294646960400256; Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV); https://cir.nii.ac.jp/crid/1360298759593526016; Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study; https://cir.nii.ac.jp/crid/1360298762034032256; Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris; https://cir.nii.ac.jp/crid/1360298762035140608; Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid; https://cir.nii.ac.jp/crid/1360298764790307456; Therapeutic effect of mizoribine on pemphigus vulgaris and pemphigus foliaceus; https://cir.nii.ac.jp/crid/1360567185631705344; Pemphigus; https://cir.nii.ac.jp/crid/1360574096342888832; Results of the guideline‐based treatment for pemphigus: a single‐centre experience with 84 cases; https://cir.nii.ac.jp/crid/1360576121783072512; Association between psoriasis and short-term outcomes of acute myocardial infarction: A matched-pair cohort study using a nationwide inpatient database in Japan; https://cir.nii.ac.jp/crid/1360580232410938752; National trends in incidence, mortality, hospitalizations, and expenditures for pemphigus in Taiwan; https://cir.nii.ac.jp/crid/1360580235820636416; Comorbidities and inpatient mortality for pemphigus in the U.S.A.; https://cir.nii.ac.jp/crid/1360580239755626496; Validity of initial cancer diagnoses in the Diagnosis Procedure Combination data in Japan; https://cir.nii.ac.jp/crid/1360857593792210048; Validity of operative information in Japanese administrative data: a chart review-based analysis of 1221 cases at a single institution; https://cir.nii.ac.jp/crid/1360861295374913152; The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality; https://cir.nii.ac.jp/crid/1360861710626696832; Epidemiology of Pemphigus; https://cir.nii.ac.jp/crid/1360861711930761088; Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries; https://cir.nii.ac.jp/crid/1361137045984412160; Correlation between the Barthel Index and care need levels in the Japanese long‐term care insurance system; https://cir.nii.ac.jp/crid/1361418521098916480; Validity of diagnoses and procedures in Japanese dental claims data; https://cir.nii.ac.jp/crid/1361699993724531840; Japanese guidelines for the management of pemphigus; https://cir.nii.ac.jp/crid/1361981470050855808; First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial; https://cir.nii.ac.jp/crid/1362262946136973568; Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data; https://cir.nii.ac.jp/crid/1362544420858732160; A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation; https://cir.nii.ac.jp/crid/1362825893344056704; https://cir.nii.ac.jp/crid/1362825893478606848; A randomized double-blind trial of intravenous immunoglobulin for pemphigus; https://cir.nii.ac.jp/crid/1363107368757520256; Diagnosis and management of pemphigus: Recommendations of an international panel of experts; https://cir.nii.ac.jp/crid/1363107371184313344; Validity of diagnoses, procedures, and laboratory data in Japanese administrative data in Japanese administrative data; https://cir.nii.ac.jp/crid/1390282679451025536; Real World Data in Japan: Chapter II The Diagnosis Procedure Combination Database; https://cir.nii.ac.jp/crid/1390566775135018240; Barthel index score predicts mortality in elderly heart failure — a goal of comprehensive cardiac rehabilitation.; https://cir.nii.ac.jp/crid/1390853443030849920; Function evaluation: the Barthel index; https://cir.nii.ac.jp/crid/1571980076267039872; Stroke rehabilitation: Analysis of repeated Barthel Index measures.; https://cir.nii.ac.jp/crid/1572261549239481600
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Crossref; https://www.crossref.org; 科学研究費助成事業データベース; https://kaken.nii.ac.jp/ja

• 要約等: <jats:title>Abstract</jats:title><jats:p>Pemphigus is a life‐threatening autoimmune blistering disease. Patient characteristics, treatment courses, an...